Physician profile
David A Ball
NPI 1851473854
$654.17
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $392 · 2020: $263.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $181.54 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $118.91 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $45.94 | 2019 | |
| Janssen Pharmaceuticals, INC | $40.14 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $38.95 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.06 | 2019-2020 | |
| Amarin Pharma, INC. | $32.85 | 2020 | |
| Pfizer INC. | $29.56 | 2019-2020 | |
| Glaxosmithkline, LLC. | $25.68 | 2020 | |
| Abbott Laboratories | $24.04 | 2019 | |
| Medtronic Vascular, INC. | $16.91 | 2020 | |
| Merck Sharp & Dohme LLC | $14.81 | 2019 | |
| Astellas Pharma US INC | $13.38 | 2019 | |
| Lilly USA, LLC | $13.36 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $11.89 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $11.15 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ball listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.